RenovoRx (RNXT) Notes Payables (2020)
RenovoRx (RNXT) posted Notes Payables of $2.6 million for Q4 2020.
RenovoRx (RNXT) Notes Payables (2020) Analysis & Trends
RenovoRx has reported Notes Payables for 1 years, with the latest figure at $2.6 million in Q4 2020.
- Quarterly Notes Payables changed N/A year-over-year to $2.6 million in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $2.6 million (changed N/A YoY) and the FY2020 annual result came in at $2.6 million, changed N/A from the prior year.
- Notes Payables was little changed at $2.6 million in Q4 2020 per RNXT's latest filing.
- Over five years, Notes Payables peaked at $2.6 million in Q4 2020 and troughed at $2.6 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | RenovoRx | 62.20 Mn | 62.20 Mn | 766,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 2.65 Mn |